Group One Trading’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Group One Trading’s Portfolio BTTX Stock Details BTTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,351	Closed	-$2.02K	–	8213
2023 Q4	$2.02K	Sell	10,351 -8,347	-45%	-$1.81K	﹤0.01%	6819
2023 Q3	$7.21K	Buy	18,698 +15,696	+523%	+$10.6K	﹤0.01%	6529
2023 Q2	$3.24K	Sell	3,002 -11,789	-80%	-$11.4K	﹤0.01%	6906
2023 Q1	$10.8K	Sell	14,791 -5,466	-27%	-$6.42K	﹤0.01%	5897
2022 Q4	$22.7K	Buy	+20,257	New	+$29.9K	﹤0.01%	5523

Other funds holding BTTX

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

APC

Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

Group One Trading's BTTX Position: Q1 2024 in Review

Group One Trading sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q1 2024, closing a stake of 10,351 shares — an estimated $2.02K sold.

Group One Trading first reported a position in BTTX in Q4 2022 and held it in 5 quarters. The position peaked at $22.7K in Q4 2022. 3 funds tracked by Wall St. Rank hold BTTX as of Q1 2024.

Group One Trading reported no remaining Better Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Group One Trading sold 10,351 Better Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.02K.
Group One Trading first reported a position in Better Therapeutics, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
Group One Trading's Better Therapeutics, Inc. Common Stock position peaked at $22.7K in Q4 2022.
3 funds tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.